North America Metastatic Lung Adenocarcinoma Treatment Market Size & Outlook
The metastatic lung adenocarcinoma treatment market in North America is expected to reach a projected revenue of US$ 3,640.2 million by 2030. A compound annual growth rate of 11.1% is expected of North America metastatic lung adenocarcinoma treatment market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,742.2
Forecast, 2030 (US$M)
$3,640.2
CAGR, 2024 - 2030
11.1%
Report Coverage
North America
North America metastatic lung adenocarcinoma treatment market, 2018-2030 (US$M)
Related Markets
North America metastatic lung adenocarcinoma treatment market highlights
- The North America metastatic lung adenocarcinoma treatment market generated a revenue of USD 1,742.2 million in 2023.
- The market is expected to grow at a CAGR of 11.1% from 2024 to 2030.
- In terms of segment, chemotherapy was the largest revenue generating treatment in 2023.
- Chemotherapy is the most lucrative treatment segment registering the fastest growth during the forecast period.
North America data book summary
| Market revenue in 2023 | USD 1,742.2 million |
| Market revenue in 2030 | USD 3,640.2 million |
| Growth rate | 11.1% (CAGR from 2023 to 2030) |
| Largest segment | Chemotherapy |
| Fastest growing segment | Chemotherapy |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Chemotherapy |
Other key industry trends
- In terms of revenue, North America region accounted for 39.5% of the global metastatic lung adenocarcinoma treatment market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,293.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Metastatic Lung adenocarcinoma Treatment Market Scope
Metastatic lung adenocarcinoma treatment market segmentation & scope
End Use
Hospitals
Specialty Clinics
Other
Countries
U.S.
Canada
Mexico
UK
Sweden
Spain
Norway
Italy
Germany
France
Denmark
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Kuwait
Thailand
South Korea
Japan
India
China
Metastatic Lung adenocarcinoma Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America metastatic lung adenocarcinoma treatment market
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
